Keyphrases
Genome-scale Metabolic Model
100%
Alpha-synuclein (α-syn)
50%
Pathophysiological Roles
50%
Whole Genome Sequencing
50%
Diagnostic Role
50%
Melanoma
50%
Microbial Community
50%
Chromohalobacter Canadensis
50%
DJ-1
50%
Salt Tolerance
50%
Modeller
25%
Foundational Concepts
25%
Parkinson's Disease
25%
Genome-scale Model
25%
Biological Knowledge
25%
Biological Data
25%
Mixed Microbial Communities
25%
Mathematical Rigour
25%
Universal Standards
25%
Computational Tools
25%
Protein-protein Interaction
18%
Metabolism
16%
Molecular Docking
12%
Lymph Node
12%
Metastatic Melanoma
12%
Melanoma Patients
12%
Melanoma Progression
12%
Temozolomide
12%
Skin Cutaneous Melanoma
12%
Systems Biology
8%
Industrial Production
8%
Biomolecules
8%
Flux Balance Analysis
8%
Stress Adaptation
8%
Salt-tolerant
8%
Minimal Media
8%
Osmotic Adaptation
8%
Osmoadaptation
8%
Polyhydroxybutyrate
8%
Phenotype Prediction
8%
Mesophile
8%
Biotechnology
8%
Industrial Biotechnology
8%
Halophiles
8%
High-throughput Technologies
8%
Genomic Data
8%
Carbon Source
8%
Draft Genome
8%
Ectoine
8%
Immunohistochemistry
6%
Medicine and Dentistry
Diagnosis
50%
Synuclein
50%
Melanoma
50%
Parkinson's Disease
25%
Protein-Protein Interaction
12%
Temozolomide
12%
Metastatic Melanoma
12%
Lymph Node
12%
Docking (Molecular)
12%
Cutaneous Melanoma
12%
Biological Marker
12%
Immunoassay
6%
Oncogene
6%
Autosomal Recessive Inheritance
6%
Enzyme Linked Immunosorbent Assay
6%
Dacarbazine
6%
Chemosensitivity
6%
Protein Binding
6%
Cellular Model
6%
Antiinfective Agent
6%
The Cancer Genome Atlas
6%
Doxorubicin
6%
Disease
6%
In Vitro
6%
Tumor Spheroid
6%
Immunohistochemistry
6%
Protein Interaction
6%
Melanoma Cell
6%
Cancer Types
6%
Drug Binding
6%
Skin Cancer
6%
Chemotherapy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Synuclein
50%
Melanoma
50%
Parkinson's Disease
22%
Biological Marker
11%
Cutaneous Melanoma
11%
Metastatic Melanoma
11%
Temozolomide
11%
Antiinfective Agent
5%
Disease
5%
Protein Binding
5%
Enzyme-Linked Immunosorbent Assay
5%
Dacarbazine
5%
Immunoassay
5%
Doxorubicin
5%
Malignant Neoplasm
5%
Skin Cancer
5%
Chemotherapy
5%
